Login / Signup

eGFR slope as a primary endpoint for clinical trials of CKD progression: one size fits all?

Balazs OdlerEdouard L Fu
Published in: Clinical kidney journal (2024)
Keyphrases
  • clinical trial
  • small cell lung cancer
  • epidermal growth factor receptor
  • chronic kidney disease
  • tyrosine kinase
  • phase ii
  • study protocol